Skip to main content

Table 3 Comparison of biochemical and clinical parameters between survivor and non-survivor with sepsis-associated liver dysfunction initially infected by bacteria enrolled in study

From: Continuous hemofiltration improves the prognosis of bacterial sepsis complicated by liver dysfunction in children

Variables

Survivors (n = 14)

Non-survivors (n = 13)

P

Cases with CRRT, n (%)

11 (78.6%)

5 (38.5%)

0.034*

Age, month, median (range)

30 (2–132)

12 (2–192)

0.704

Male, n (%)

5 (35.7%)

8 (61.5%)

0.180

Stay in PICU, day, median (range)

9.5 (4–36)

10 (4–28)

1.000

Body temperature, oC

39 (38–40)

38.8 (36–41)

0.678

Hepatomegaly, n (%)

10 (71.4%)

6 (46.2%)

0.182

Hypoproteinemia, n (%)

9 (64.3%)

13 (100%)

0.083

Pediatric Risk of Mortality III

(PRISM III), median (range)

12.55 (10–17)

14.6 (10–20)

0.252

Co-organ dysfunction

 ARDS, n (%)

9 (64.3%)

4 (30.8%)

0.082

 Kidney injury, n (%)

5 (35.7%)

6 (46.2%)

0.581

 Encephalopathy, n (%)

4 (28.6%)

6 (46.2%)

0.585

 Shock, n (%)

5 (35.7%)

8 (61.5%)

0.180

Infection origin

 Respiratory system, n (%)

8 (57.1%)

3 (23.1%)

0.072

 Digestive system, n (%)

3 (21.4%)

4 (30.8%)

0.580

 Urinary system, n (%)

2 (14.3%)

1 (7.7%)

0.586

 Central nervous system, n (%)

1 (7.1%)

5 (38.5%)

0.050

Pathogens

Escherichia coli, n

5 (35.7%)

5 (38.5%)

0.883

Pseudomonas aeruginosa, n

4 (28.6%)

2 (15.4%)

0.406

Klebsiellapneumoniae, n

1 (7.1%)

0 (0%)

1.000

Streptococcus pneumoniae, n

4 (28.6%)

3 (23.1%)

0.744

Staphylococcus aureus, n

0 (0%)

3 (23.1%)

0.172

Infection markers

 WBC

11.10 ± 8.48

12.96 ± 6.43

0.528

 PCT

5.71 ± 3.64

6.13 ± 4.96

0.805

 CRP

90.07 ± 44.65

106.92 ± 61.66

0.421

Liver function

 ALT

484.21 ± 128.89

643.94 ± 303.62

0.083

 AST

1059.50 ± 848.05

954.94 ± 651.32

0.724

 γ-GT

143.57 ± 69.92

205.46 ± 144.19

0.163

 TBIL

134.55 ± 127.51

232.99 ± 88.49

0.029*

 DBIL

108.89 ± 88.00

169.99 ± 79.64

0.071

 TBA

92.22 ± 21.47

111.93 ± 31.51

0.067

 ALP

166.43 ± 33.24

172.23 ± 32.84

0.653

 PT

20.56 ± 6.47

31.62 ± 26.07

0.136

 APTT

58.83 ± 23.16

66.46 ± 33.73

0.497

 INR

1.55 ± 0.37

2.41 ± 1.94

0.117

 Fib

1.51 ± 0.73

1.91 ± 0.76

0.171

 Lac

4.20 ± 3.45

5.50 ± 3.99

0.410

 Ammonia

139.07 ± 62.24

182.06 ± 75.11

0.122

 TNF-α

96.89 ± 30.65

117.89 ± 37.66

0.123

 IL-6

75.78 ± 21.75

92.27 ± 27.70

0.096

  1. ALT alanine transaminase, U/L, AST aspartate aminotransferase, U/L, γ-GT γ-glutamyltransferase, U/L, TBIL total bilirubin, μmol/L, DBIL direct bilirubin, μmol/L, TBA total bile acid, μmol/L, ALP alkaline phosphatase, U/L, PT prothrombin time, s, APTT activated partial thromboplastin time, s, INR international normalized ratio, Fib ferritin, g/L, Lac lactate, mmol/L; Ammonia, μmol/L, TNF-α tumor necrosis factor α, pg/mL, IL-6 interleukin 6, pg/mL
  2. * indicates P < 0.05 compared with survivors